1. Home
  2. ANTA vs TNXP Comparison

ANTA vs TNXP Comparison

Compare ANTA & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANTA
  • TNXP
  • Stock Information
  • Founded
  • ANTA 2022
  • TNXP 2007
  • Country
  • ANTA Singapore
  • TNXP United States
  • Employees
  • ANTA N/A
  • TNXP N/A
  • Industry
  • ANTA Investment Bankers/Brokers/Service
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANTA Finance
  • TNXP Health Care
  • Exchange
  • ANTA Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • ANTA 301.9M
  • TNXP 335.6M
  • IPO Year
  • ANTA 2025
  • TNXP N/A
  • Fundamental
  • Price
  • ANTA $13.19
  • TNXP $27.08
  • Analyst Decision
  • ANTA Strong Buy
  • TNXP Buy
  • Analyst Count
  • ANTA 2
  • TNXP 1
  • Target Price
  • ANTA $19.25
  • TNXP $70.00
  • AVG Volume (30 Days)
  • ANTA 25.3K
  • TNXP 1.9M
  • Earning Date
  • ANTA 08-12-2025
  • TNXP 08-11-2025
  • Dividend Yield
  • ANTA N/A
  • TNXP N/A
  • EPS Growth
  • ANTA N/A
  • TNXP N/A
  • EPS
  • ANTA 0.24
  • TNXP N/A
  • Revenue
  • ANTA $56,997,910.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • ANTA $63.16
  • TNXP $21.19
  • Revenue Next Year
  • ANTA $40.86
  • TNXP $722.94
  • P/E Ratio
  • ANTA $55.25
  • TNXP N/A
  • Revenue Growth
  • ANTA 405.62
  • TNXP N/A
  • 52 Week Low
  • ANTA $10.19
  • TNXP $6.76
  • 52 Week High
  • ANTA $27.72
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • ANTA N/A
  • TNXP 33.04
  • Support Level
  • ANTA N/A
  • TNXP $34.50
  • Resistance Level
  • ANTA N/A
  • TNXP $29.70
  • Average True Range (ATR)
  • ANTA 0.00
  • TNXP 3.74
  • MACD
  • ANTA 0.00
  • TNXP -1.68
  • Stochastic Oscillator
  • ANTA 0.00
  • TNXP 1.78

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: